This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

New Zealand regulator investigating Reckitt Benckiser following Australian court ruling

( December 15, 2015, 06:20 GMT | Insight) -- New Zealand's Commerce Commission is investigating multi-billion dollar pharmaceutical and consumer goods giant Reckitt Benckiser after it was found guilty by an Australian court for misleading consumers with identical Nurofen-branded formulations that wer...New Zealand’s Commerce Commission is investigating multi-billion dollar pharmaceutical and consumer goods giant Reckitt Benckiser after it was found guilty by an Australian court for misleading consumers with identical Nurofen-branded formulations that were marketed and priced differently, the National Business Review reported. Reckitt Benckiser NZ said the Australian case did not apply to New Zealand, which performs rigorous reviews on products before granting licenses, and that Nurofen New Zealand will continue to cooperate with regulators to ensure compliance with packaging guidelines. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login